MICROBOT MEDICAL INC (MBOT) Stock Earnings & Estimates
NASDAQ:MBOT - US59503A2042 - Common Stock
4.07 USD
+0.19 (+4.9%)
4.1 USD
+0.03 (+0.74%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.01M | 110.16K -100.00% | N/A | 1.663M | 13.77M 728.02% | |||||||||
| EBITDA YoY % growth | -29.6M | -38.993M 96.96% | N/A -970.00% | N/A 45.48% | N/A -36.95% | N/A 0.42% | N/A -25.98% | N/A -25.06% | N/A -16.84% | N/A 26.03% | N/A -18.31% | N/A | N/A | |
| EBIT YoY % growth | -30.91M | -38.817M 97.02% | N/A -947.83% | -6.661M 45.33% | -7.079M -37.38% | -7.193M | -9.039M -25.55% | -10.22M -24.97% | -13.987M -16.90% | -11.366M 25.79% | -11.674M -17.96% | -11.802M -1.53% | -8.415M 28.70% | |
| Operating Margin | -3,060.40% | -35,236.88% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -709.71% | -61.11% | |
| EPS YoY % growth | -826.20 | -637.83 21.57% | N/A | -2.75 | -0.32 14.67% | -1.59 27.23% | -1.28 24.56% | -1.44 -23.26% | -1.94 -15.72% | -1.11 46.20% | -0.72 25.25% | -0.35 53.14% | -0.26 26.47% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 59.20% | -0.07 64.30% | -0.07 20.67% | -0.06 38.80% | -0.06 25.00% | -0.04 42.86% |
| Revenue Q2Q % growth | 1.02M | 2.04M | 3.06M | 3.57M | 4.08M 300.00% | 4.59M 125.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.907M 11.91% | -2.754M 19.71% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.10 41.18% | -0.08 | -0.02 | -22.55% |
| Q1 2025 Q2Q % growth | -0.09 47.06% | -0.13 | 0.04 | 32.13% |
| Q4 2024 Q2Q % growth | -0.20 -17.65% | -0.18 | -0.02 | -8.93% |
| Q3 2024 Q2Q % growth | -0.20 4.76% | -0.17 | -0.03 | -15.34% |
| Q2 2024 Q2Q % growth | -0.17 32.00% | -0.17 | 0.00 | 1.96% |
| Q1 2024 Q2Q % growth | -0.17 52.78% | -0.17 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.17 58.54% | -0.26 | 0.08 | 33.33% |
| Q3 2023 Q2Q % growth | -0.21 57.14% | -0.26 | 0.05 | 17.65% |
| Q2 2023 Q2Q % growth | -0.25 48.98% | -0.32 | 0.07 | 20.94% |
| Q1 2023 Q2Q % growth | -0.36 20.00% | -0.46 | 0.10 | 21.57% |
| Q4 2022 Q2Q % growth | -0.41 24.07% | -0.48 | 0.07 | 14.48% |
| Q3 2022 Q2Q % growth | -0.49 -36.11% | -0.52 | 0.03 | 5.81% |
| Q2 2022 Q2Q % growth | -0.49 -40.00% | -0.46 | -0.03 | -6.75% |
| Q1 2022 Q2Q % growth | -0.45 -32.35% | -0.43 | -0.02 | -5.04% |
| Q4 2021 Q2Q % growth | -0.54 -45.95% | -0.38 | -0.16 | -43.08% |
| Q3 2021 Q2Q % growth | -0.36 -2.86% | -0.37 | 0.01 | 1.96% |
| Q2 2021 Q2Q % growth | -0.35 -34.62% | -0.36 | 0.01 | 1.96% |
| Q1 2021 Q2Q % growth | -0.34 -9.68% | -0.34 | 0.00 | -1.01% |
| Q4 2020 Q2Q % growth | -0.37 13.95% | -0.35 | -0.02 | -6.69% |
| Q3 2020 Q2Q % growth | -0.35 20.45% | -0.29 | -0.06 | -22.55% |
| Q2 2020 Q2Q % growth | -0.26 27.78% | -0.28 | 0.02 | 5.59% |
| Q1 2020 Q2Q % growth | -0.31 35.42% | -0.29 | -0.02 | -8.54% |
| Q4 2019 Q2Q % growth | -0.43 | -0.32 | -0.11 | -35.99% |
| Q3 2019 Q2Q % growth | -0.44 | -0.37 | -0.07 | -19.83% |
| Q2 2019 Q2Q % growth | -0.36 | -0.42 | 0.06 | 14.95% |
| Q1 2019 Q2Q % growth | -0.48 | -0.43 | -0.05 | -12.04% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2020 Q2Q % growth | 202.999K | -202.999K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 38.46% | -6.25% | 15% |
| Revenue | 0% | -50% | -45.65% | -72.83% |